Skip to main content
. Author manuscript; available in PMC: 2013 Jan 30.
Published in final edited form as: J Control Release. 2011 Sep 22;157(2):216–223. doi: 10.1016/j.jconrel.2011.09.076

Figure 4.

Figure 4

Biodistribution in female athymic nude mice bearing CHO and CHO-CXCR4 tumors at 4 h post injection of (A) 64Cu-DOTA-NFB (black bars) and co-injection of 64Cu-DOTA-NFB with 50 µg of unlabeled DOTA-NFB for blocking studies (dash bars); and (B) 64Cu-NOTA-NFB (black bars) and co-injection of 64Cu-NOTA-NFB with 50 µg of NOTA-NFB (dash bars). Results shown are averages of 5–6 mice ± SE. *P < 0.01 vs. 64Cu-DOTA-NFB or 64Cu-NOTA-NFB alone.